Development of cellular immunity in cutaneous leishmaniasis due to Leishmania tropica

A laboratory worker was inadvertently inoculated with infectious material while passaging amastigotes of Leishmania tropica. The subsequent development of a cutaneous lesion was correlated with results of sequential in vitro bioassays of cell-mediated immunity. Induction of lymphocyte proliferation...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 150; no. 1; pp. 135 - 138
Main Authors: Sadick, M.D, Locksley, R.M, Raff, H.V
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 01-07-1984
University of Chicago Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A laboratory worker was inadvertently inoculated with infectious material while passaging amastigotes of Leishmania tropica. The subsequent development of a cutaneous lesion was correlated with results of sequential in vitro bioassays of cell-mediated immunity. Induction of lymphocyte proliferation and interleukin 2 production by soluble L. tropica antigens appeared within five weeks of infection and reached maximal levels coincident with ulceration of the skin lesion. Thereafter interleukin 2 production rapidly decreased, whereas the lymphocyte proliferative response declined more slowly. Biopsy of the lesion after 12 weeks, at a time when antigen-induced lymphocyte proliferation was still significantly elevated but interleukin 2 activity had returned to near baseline values, demonstrated no organisms either histologically or by culture. Healing was complete after 20 weeks. These studies provide data on the kinetics of the development of cell-mediated immunity in human cutaneous leishmaniasis and suggest the usefulness of in vitro bioassays of specific immune reactivity to parasites for evaluating effective cell-mediated immunity.
Bibliography:ark:/67375/HXZ-BQZDH4ZF-K
Informed consent was obtained from the patient, and all guidelines for the study of human subjects prescribed by the University of Washington were followed in the conduct of this research.
istex:B2B29B98E0999D1F83129E2ECBAD69EFA6D3D481
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Case Study-2
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/150.1.135